Revision Skincare
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Revision Skincare sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
Revision Skincare: 18 sponsored US clinical trials, none currently recruiting.
Revision Skincare sponsors 18 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 18 completed. The most-studied condition in this pipeline is Fine Lines, with 4 trials.
Top-decile sponsor footprint
Revision Skincare ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
18 total, page 1 of 1
A 4-week Study Investigating Two Targeted Brightening Serum (A and B) Versus 4% Hydroquinone in Women With Mild to Severe Full-face Hyperpigmentation
NCT07644871
A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation
NCT07468175
Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen
NCT07501000
Efficacy and Tolerability of a Scalp Serum
NCT07500623
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
NCT06366503
Clinical Case Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment on Healthy Females with Fitzpatrick Skin Types V and VI
NCT06633731
A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+
NCT06148558
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation
NCT06157853
A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation
NCT06629792
A 12 Week Study to Evaluate the Efficacy of an Eye Cream
NCT05807620
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation
NCT06436261
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum
NCT05514782
A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging
NCT05423873
A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum
NCT05271136
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
NCT04911374
Investigation of the Efficacy and Tolerability of a Cosmetic Product With Onabotulinumtoxin A in the Treatment of Facial Lines
NCT05089851
A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines
NCT04545970
A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming
NCT04065035
Therapeutic Areas
How the Revision Skincare archive is shaped
18 indexed studies, none listed as recruiting (0% open); 18 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Fine Lines (4 trials), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Revision Skincare: archived-pipeline peers nationwide
Peers matched on 18 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Revision Skincare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 archived trials
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- AO Innovation Translation Center · 18 trials · 33% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Revision Skincare page
18 registered trials is a research-attention snapshot, not an endorsement of Revision Skincare or any single study.
- None of Revision Skincare's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Fine Lines is the condition Revision Skincare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Fine Lines trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Revision Skincare pipeline card: 18 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.